Knome kick-starts release of software for genome interpretation; Datatrak inks multimillion-dollar eClinical deal;

> Knome, a Cambridge, MA-based provider of genomics software, says the company has begun an early access program for KnomeClinic, which is a collection of software tools intended to help medical researchers and providers interpret genomic data. Release

> Knome also appointed Gary Cohen, formerly a legal executive for the startup Foundation Medicine, as Knome's senior vice president and general counsel. Announcement

> CLC bio has implemented an antibody engineering software module for the Crucell unit within the Johnson & Johnson ($JNJ) corporate family. Item

> Biolauncher, a Cambridge, U.K., consulting firm that uses in-house informatics, has joined forces with Isogenica and Cresset Group in a £1 million ($1.24 million) effort to create a platform for discovery of small molecule drugs. Release

> Datatrak International ($DATA) says the global CRO Pharm-Olam International has inked a multimillion-dollar contract to use Datatrak's clinical research software. Release

> PerkinElmer ($PKI) plans to make 100 new hires to staff a center for personalized medicine in Hopkinton, MA. Article | Release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.